-transparent.png){kind=logo}
The effects of serotonin precursors (L-5-hydroxytryptophan and L-tryptophan, with or without MAO inhibitors) and of agonists (quipazine and 5-methoxy-N,N-dimethyltryptamine-MeO-DMT) were studied in 3 day REM-deprived or control rats, by recording the presence of the serotonin syndrome and the number of head shakes. The REM sleep-deprived rats showed a larger incidence of the serotonin syndrome and a greater number of head shakes in comparison to the control animals, when challenged with the serotonin precursors. Conversely, REM sleep deprivation did not modify the responsiveness of rats to 0.75-6.0 mg/kg of MeO-DMT and to 2.4-6.0 mg/kg of quipazine. However, REM-deprived rats reacted less than controls to 0.3-1.25 mg/kg of quipazine. Increased turnover due to REM sleep deprivation could explain the augmented responsiveness of the rats to the serotonin precursors. Conversely, the decreased responsiveness to quipazine could result from receptor hyposensitivity due to intense receptor activation, caused by the increased turnover, during the 3 day period of REM sleep deprivation.
R Santos, and
E A Carlini
March 2020,
Behavioural brain research,
R Santos, and
E A Carlini
January 2010,
International journal of endocrinology,
R Santos, and
E A Carlini
April 1979,
Life sciences,
R Santos, and
E A Carlini
January 1984,
Physiology & behavior,
R Santos, and
E A Carlini
March 1982,
Brain research bulletin,
R Santos, and
E A Carlini
May 1984,
Pharmacology, biochemistry, and behavior,
R Santos, and
E A Carlini
March 2018,
Progress in neuro-psychopharmacology & biological psychiatry,
R Santos, and
E A Carlini
September 1982,
Behavioural brain research,
R Santos, and
E A Carlini
January 1996,
Physiology & behavior,
R Santos, and
E A Carlini
January 1975,
Pharmacology, biochemistry, and behavior,
